Combinations of Anticyclic Citrullinated Protein Antibody, Rheumatoid Factor, and Serum Calprotectin Positivity Are Associated With the Diagnosis of Rheumatoid Arthritis Within 3 Years-Reference-Cited by-同舟云学术

Combinations of Anticyclic Citrullinated Protein Antibody, Rheumatoid Factor, and Serum Calprotectin Positivity Are Associated With the Diagnosis of Rheumatoid Arthritis Within 3 Years

Published:2021-07-20 Issue:10 Volume:3 Page:684-689
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Bettner Leah F.¹,Peterson Ryan A.²,Bergstedt Dylan T.³,Kelmenson Lindsay B.⁴,Demoruelle M. Kristen³^ORCID,Mikuls Ted R.⁵^ORCID,Edison Jess D.⁶,Parish Mark C.³,Feser Marie L.³,Frazer‐Abel Ashley A.³,Moss Laura K.³,Mahler Michael⁷^ORCID,Holers V. Michael³,Deane Kevin D.³^ORCID

Affiliation:

1. University of Colorado, Aurora, Colorado, and University of North Carolina at Chapel Hill

2. University of Colorado and Colorado School of Public Health Aurora

3. University of Colorado Aurora Colorado

4. Rheumatology Care Center Hoover Alabama

5. Veterans Affairs Nebraska‐Western Iowa Health Care System and University of Nebraska Medical Center Omaha Nebraska

6. Walter Reed National Military Medical Center Bethesda Maryland

7. Inova Diagnostics San Diego California

Funder

National Institutes of Health

Congressionally Directed Medical Research Programs

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11309

Reference17 articles.

1. Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift

2. Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study

3. Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

4. National Institute of Allergy and Infectious Diseases sponsor.Strategy to prevent the onset of clinically‐apparent rheumatoid arthritis (StopRA). Clinicaltrials.gov identifier: NCT02603146.

5. Calprotectin in rheumatic diseases

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi‐Autoantibody Testing Identifies Expansion of Reactivity to Targeted Antigens Before a Diagnosis of Rheumatoid Arthritis;ACR Open Rheumatology;2024-07

2. In Vivo Study to Explore the Antiarthritic Potential of Tiliroside on Complete Freund’s Adjuvant-Induced Rheumatoid Arthritis in Rats;Revista Brasileira de Farmacognosia;2024-05-29

3. The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis;Current Issues in Molecular Biology;2024-04-19

4. Circulating calprotectin in rheumatoid arthritis: unravelling the impact of (pre-)analytical confounders on meta-analysis results;Journal of Laboratory and Precision Medicine;2024-04

5. A quantitative and site-specific atlas of the citrullinome reveals widespread existence of citrullination and insights into PADI4 substrates;Nature Structural & Molecular Biology;2024-02-06